Zasocitinib
CAS 2272904-53-5
Em Estoque
Zasocitinib
Cat. No. STUB-API-ZASOCITINIB-APICAS 2272904-53-5Em Estoque
Dados Técnicos
Cat. No.STUB-API-ZASOCITINIB-API
CAS2272904-53-5
Fórmula Mol.C23H24N8O3
Peso Mol.460.498 g/mol
IUPACN-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-yl-3-pyridinyl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCNC1=CC(=NC2=C(C=NN12)C(=O)N[C@@H]3CC[C@H]3OC)NC4=CC=CN(C4=O)C5=CC=CC=N5
InChIInChI=1S/C23H24N8O3/c1-24-20-12-18(27-16-6-5-11-30(23(16)33)19-7-3-4-10-25-19)29-21-14(13-26-31(20)21)22(32)28-15-8-9-17(15)34-2/h3-7,10-13,15,17,24H,8-9H2,1-2H3,(H,27,29)(H,28,32)/t15-,17-/m1/s1
Chave InChIBWINBHTTZLVXGT-NVXWUHKLSA-N
Pureza—
Descrição
Visão geral
Zasocitinib (formerly TAK-279) is an oral, highly selective, allosteric tyrosine kinase 2 (TYK2) inhibitor being developed by Takeda Pharmaceuticals for inflammatory conditions, including moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease
A Anant Labs fabrica e fornece impurezas de Zasocitinib de alta qualidade para o mercado global. Nossas impurezas EP de Zasocitinib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
2272904-53-5N-((1R,2R)-2-Methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-[1,2'-bipyridin]-3-yl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxamideN-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-pyrazolo[1,5-a]pyrimidine-3-carboxamideN-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo(1(2H),2'-bipyridin)-3-yl)amino)-pyrazolo(1,5-a)pyrimidine-3-carboxamideN-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-(1,2'-bipyridin)-3-yl)amino)pyrazolo(1,5-a)pyrimidine-3-carboxamideRefChem:822799957-394-0960-464-3ZasocitinibNDI-034858
